Invention Grant
- Patent Title: Genetically stable oncolytic RNA virus, method of manufacturing and use thereof
-
Application No.: US16144102Application Date: 2018-09-27
-
Publication No.: US10435672B2Publication Date: 2019-10-08
- Inventor: Dite Venskus , Ivars Kalvins , Dace Pjanova , Ramona Petrovska , Jurgis Auzins
- Applicant: Ditesan Ltd.
- Applicant Address: LV Riga
- Assignee: DITESAN LTD.
- Current Assignee: DITESAN LTD.
- Current Assignee Address: LV Riga
- Agency: Duane Morris LLP
- Agent Thomas J. Kowalski; Deborah L. Lu
- Priority: EP13176757 20130716
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N7/00 ; A01K67/00

Abstract:
In a method for manufacturing a modified enterovirus of ECHO 7 type by modification of native ECHO 7 virus, isolated by a known method from human feces and identified by genome sequence, the modification is performed initially conducting the virus adaptation in cancer cells, attenuated by anti-cancer agent dacarbazine, further passaging the modified virus in human embryonal fibroblast culture, followed by propagation in human melanoma cells and further passaging in human embryonal fibroblast culture, that was treated by ribavirin, isolation and purification by known method. The modified virus is suitable for treating various tumors.
Public/Granted literature
- US20190144833A1 GENETICALLY STABLE ONCOLYTIC RNA VIRUS, METHOD OF MANUFACTURING AND USE THEREOF Public/Granted day:2019-05-16
Information query